首页> 外文期刊>Bioinformatics >Small-molecule inhibitor starting points learned from protein-protein interaction inhibitor structure
【24h】

Small-molecule inhibitor starting points learned from protein-protein interaction inhibitor structure

机译:从蛋白质-蛋白质相互作用抑制剂结构中学到的小分子抑制剂起点

获取原文
获取原文并翻译 | 示例
       

摘要

Motivation: Protein-protein interactions (PPIs) are a promising, but challenging target for pharmaceutical intervention. One approach for addressing these difficult targets is the rational design of small-molecule inhibitors that mimic the chemical and physical properties of small clusters of key residues at the protein-protein interface. The identification of appropriate clusters of interface residues provides starting points for inhibitor design and supports an overall assessment of the susceptibility of PPIs to small-molecule inhibition.Results: We extract Small-Molecule Inhibitor Starting Points (SMISPs) from protein-ligand and protein-protein complexes in the Protein Data Bank (PDB). These SMISPs are used to train two distinct classifiers, a support vector machine and an easy to interpret exhaustive rule classifier. Both classifiers achieve better than 70% leave-one-complex-out cross-validation accuracy and correctly predict SMISPs of known PPI inhibitors not in the training set. A PDB-wide analysis suggests that nearly half of all PPIs may be susceptible to small-molecule inhibition.
机译:动机:蛋白质-蛋白质相互作用(PPI)是药物干预的有希望但具有挑战性的目标。解决这些困难目标的一种方法是合理设计小分子抑制剂,该抑制剂模仿蛋白质-蛋白质界面上关键残基的小簇的化学和物理性质。确定合适的界面残基簇可为抑制剂设计提供起点,并支持对PPI对小分子抑制的敏感性的整体评估。结果:我们从蛋白质配体和蛋白质中提取了小分子抑制剂起点(SMISP)。蛋白质数据库(PDB)中的蛋白质复合物。这些SMISP用于训练两个不同的分类器,即支持向量机和易于理解的详尽规则分类器。两种分类器均达到了优于70%的留一复出交叉验证准确性,并且可以正确预测不在训练集中的已知PPI抑制剂的SMISP。整个PDB的分析表明,所有PPI的近一半可能易受小分子抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号